| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/28/2005 | WO2005037273A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 04/28/2005 | WO2005037272A1 Benzimidazole derivatives and use thereof as peptide deformylase inhibitors |
| 04/28/2005 | WO2005037271A2 Large conductance calcium-activated k channel opener |
| 04/28/2005 | WO2005037257A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005037199A2 Pyrazole derivatives as cannabinoid receptor modulators |
| 04/28/2005 | WO2005019168A3 Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors |
| 04/28/2005 | WO2005014517A3 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 04/28/2005 | WO2004106299A3 Substituted pyrrole derivatives and their use as hmg-co inhibitors |
| 04/28/2005 | WO2004065548A3 Synthetic molecules for labeling histidine-rich proteins |
| 04/28/2005 | WO2004065539A3 Androgen receptor antagonists |
| 04/28/2005 | US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 04/28/2005 | US20050090667 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 04/28/2005 | US20050090546 Compounds such as N,N-dibenzylphenylalanine benzyl ester, used as enzyme inhibitors; prophylaxis of lymphadenopathy associated virus, cancer and malaria |
| 04/28/2005 | US20050090542 crystalline polymorphic dosage forms of anticholesterol agents; statins |
| 04/28/2005 | US20050090541 Indolinone derivatives and their use in treating disease-states such as cancer |
| 04/28/2005 | US20050090524 Novel adamantane derivatives |
| 04/28/2005 | US20050090519 1-Alkyl-4-(3-substitutedphenyl)piperidines |
| 04/28/2005 | US20050090503 5-HT receptor ligands and uses thereof |
| 04/28/2005 | US20050090501 Heteroaryl-cyclic acetals |
| 04/28/2005 | US20050090498 3-Quinolin-2(1h)-ylideneindolin-2-one derivative |
| 04/28/2005 | US20050090485 7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders |
| 04/28/2005 | US20050089718 Pyran derivative |
| 04/28/2005 | US20050089713 Organic electroluminescent element |
| 04/28/2005 | CA2542807A1 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | CA2542723A1 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | CA2542653A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 04/28/2005 | CA2542076A1 Substituted tricyclic compounds as protein kinase inhibitors |
| 04/28/2005 | CA2541509A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/28/2005 | CA2539755A1 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 04/27/2005 | EP1525190A1 Cck-1 receptor modulators |
| 04/27/2005 | EP1525185A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 04/27/2005 | EP1524979A2 New effector conjugates, process for their production and their pharmaceutical use |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | EP1423110A4 Cbi analogues of cc-1065 and the duocarmycins |
| 04/27/2005 | EP1373202B1 Preparation of non-crystalline atorvastatin calcium |
| 04/27/2005 | EP1261327B1 Adenosine receptor modulators |
| 04/27/2005 | EP0964861B1 Process for the production of tetrazolylbenzopyrans |
| 04/27/2005 | EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/27/2005 | CN1610678A Pyrrolidone carboxamides |
| 04/27/2005 | CN1610671A Quinoline compounds with 5-HT-antagonistic properties for therapy |
| 04/27/2005 | CN1610547A N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor |
| 04/27/2005 | CN1610546A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 04/27/2005 | CN1198820C N-substituted nitrogen heterocyclic compound |
| 04/27/2005 | CN1198813C Benzofuran derivatives their preparation and use |
| 04/27/2005 | CN1198807C 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical composition containing the same |
| 04/27/2005 | CN1198806C Oxodiethylenediamine derivative and light stabilized composition |
| 04/27/2005 | CN1198804C Amide compounds and use thereof |
| 04/27/2005 | CN1198801C Indole derivatives |
| 04/27/2005 | CN1198618C Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 04/26/2005 | US6884895 Using dihydropyran, triethyl orthoformate and alkyl acrylate |
| 04/26/2005 | US6884892 Production methods of epoxytriazole derivative and intermediate therefor |
| 04/26/2005 | US6884815 An amino compound containing imidazole and aromatic, or heteroaromatic rings is useful for treating inflammatory and immune system disorders |
| 04/26/2005 | US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases |
| 04/26/2005 | US6884804 Inhibitors of Src and other protein kinases |
| 04/26/2005 | US6884802 Phenanthridines substituted in position 6 by a mono, bi- or tricyclic heteroaryl radical; cyclic nucleotidephosphoesterase (PDE4) inhibitor and useful for treating respiratory system disorders |
| 04/26/2005 | US6884801 Nitrogen compounds such as N-(4,5-dihydro-1H-imidazol-2-yl-methyl)-2-(methylsulfonyl)aniline, used for prophylaxis of incontinence |
| 04/26/2005 | US6884782 Amino acid containing compounds useful as modulators of the immune system |
| 04/26/2005 | US6884758 2,4-Diamino-1,3,5-triazines, their preparation, and their use as herbicides and plant growth regulators |
| 04/26/2005 | CA2213124C Benzoyl derivatives |
| 04/21/2005 | WO2005035529A1 Substituted phenanthropyrans |
| 04/21/2005 | WO2005035524A1 Pyrrolidinyl urea derivatives as angiogensis inhibitors |
| 04/21/2005 | WO2005035522A1 1-‘2-(4-hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists |
| 04/21/2005 | WO2005035521A1 Substituted quinolines as mcr modulators |
| 04/21/2005 | WO2005035510A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
| 04/21/2005 | WO2005035508A2 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 04/21/2005 | WO2005035507A2 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders |
| 04/21/2005 | WO2005035499A1 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
| 04/21/2005 | WO2005034955A1 Substituted quinolines as protein tyrosine kinase enzyme inhibitors |
| 04/21/2005 | WO2005034940A2 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases |
| 04/21/2005 | WO2005034870A2 Amide compounds and ion channel ligands and uses thereof |
| 04/21/2005 | WO2005034856A2 Targeted drug-formaldehyde conjugates and methods of making and using the same |
| 04/21/2005 | WO2005020882A3 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 04/21/2005 | WO2005005414A3 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 04/21/2005 | WO2005004606A3 Pyridinylanilides |
| 04/21/2005 | WO2004094375A3 4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors |
| 04/21/2005 | US20050085638 Process for producing dioxolane nucleoside analogues |
| 04/21/2005 | US20050085519 Controlling cell differentiation, cell proliferation; anticancer agents |
| 04/21/2005 | US20050085510 Drug for gastrointestinal disorders |
| 04/21/2005 | US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders |
| 04/21/2005 | US20050085508 Gastrointestinal disorders; antiemetic agents; irritable bowel disorders; antipruritic agents |
| 04/21/2005 | US20050085507 p-phenylethenyl hydroxamates; anticarcinogenic, antitumor, antiproliferative agents; regulating p21 promoter; improved stability |
| 04/21/2005 | US20050085505 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 |
| 04/21/2005 | US20050085496 Microbiocidal n-phenyl-n-{4-(4-pyridyl)-2-pyrimidin-2-yl}-amine derivatives |
| 04/21/2005 | US20050085495 Reacting with acry bromide compound; activation withphosphonacetic acid compound; antitumor agents |
| 04/21/2005 | US20050085476 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 04/21/2005 | US20050085467 Androgen receptor antagonists |
| 04/21/2005 | US20050085466 such as 1-[4-(2-oxo-4-trifluoromethyl-1,2-dihydroquinolin-6-ylmethyl)benzenesulfonyl]-piperidine-3-carboxylic acid ethyl ester; for treatment of acne, alopecia, and oily skin; kits |
| 04/21/2005 | US20050085461 Benzenesulfonamide derivatives |
| 04/21/2005 | US20050085457 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 04/21/2005 | US20050084451 Novel chelating agents and chelates and their use |
| 04/21/2005 | CA2542031A1 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 04/21/2005 | CA2541831A1 1-'2-(4-hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists |
| 04/21/2005 | CA2540868A1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors |
| 04/20/2005 | EP1523473A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 04/20/2005 | EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors |
| 04/20/2005 | EP1140904B1 Farnesyl protein transferase inhibitors |
| 04/20/2005 | EP1129077B1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 04/20/2005 | EP0766669B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 04/20/2005 | CN1608064A Novel compounds |
| 04/20/2005 | CN1608061A Therapeutic isoquinoline compounds |